Last updated: 11/07/2018 17:22:13
Interaction Study of 975mg Aspirin Given at Steady State of 10mg/sc SR90107A/Org31540 in Healthy Male Subjects
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Interaction Study of 975mg Aspirin Given at Steady State of 10mg/sc SR90107A/Org31540 in Healthy Male Subjects
Trial description: Interaction Study of 975mg Aspirin Given at Steady State of 10mg/sc SR90107A/Org31540 in Healthy Male Subjects
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers. Ollier, C., Faaij, R. A., Santoni, A., Duvauchelle, T., van Haard, P. M., Schoemaker, R. C., Cohen, A. F., de Greef, R., and Burggraaf, J. Clin Pharmacokinet 2002; 41 Suppl 2(31-7)
Donat F. The pharmacokinetics of fondaparinux sodium in healthy volunteers, Clin Pharmacokinet 2002; 41 sup.2 : 1-9.
Ollier C. Interaction of fondaparinux sodium with acetylsalicylic acid and piroxicam in healthy male volunteers, Clin. Pharmacokinet 2002; 41 sup.2: 31-37.
Medical condition
Healthy Subjects
Product
fondaparinux sodium
Collaborators
Not applicable
Study date(s)
December 1997 to April 1998
Type
Not applicable
Phase
1
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1998-30-04
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website